Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria. - Gansane, Adama; Lingani, Moussa; Yeka, Adoke; Nahum, Alain; Bouyou-Akotet, Marielle; Mombo-Ngoma, Ghyslain; Kaguthi, Grace; Barceló, Catalina; Laurijssens, Bart; Cantalloube, Cathy; Macintyre, Fiona; Djeriou, Elhadj; et al. (Malaria Journal, 2023)